Investigational drug · Phase 3
GS1191-0445
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Severe Hemophilia A, Hemophilia A.
Phase 3Last checked: Nov 20, 2026Latest source record: May 6, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "GS1191-0445"
First trial start
2023
Jul 10, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "GS1191-0445", any sponsor or status.
Conditions studied
As listed on its trial records.
- Severe Hemophilia A
- Hemophilia A
Approved drugs for the same conditions: Hemophilia · Hematology and blood cancers
Largest trials
Live from ClinicalTrials.gov: studies naming "GS1191-0445" as an intervention, largest first.
- To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia APivotal-lookingRecruiting
Gritgen Therapeutics Co., Ltd.Industry
NCT06833983 · 50 participants (planned) · Start Mar 31, 2025 · Primary completion Nov 30, 2026
Drug: GS1191-0445 injection · For: Hemophilia A
Sites: Hefei, China; Beijing, China; Lanzhou, China · 13 sites in all
- To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia AActive, not recruiting
Gritgen Therapeutics Co., Ltd.Industry
NCT07548411 · 7 participants · Start Jul 10, 2023 · Primary completion Dec 31, 2024
Drug: GS1191-0445 injection · For: Severe Hemophilia A
Sites: Wuhan, China; Tianjin, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Severe Hemophilia A
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.